Viemed Healthcare, Inc.VMDNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +19.62% | +16.87% | +14.72% | +23.98% | +25.51% |
| Gross Profit Growth | +12.54% | +11.67% | +10.60% | +20.29% | +18.91% |
| EBITDA Growth | +13.93% | +22.18% | +27.78% | +8.65% | +27.70% |
| Operating Income Growth | +21.99% | +74.27% | +24.78% | +0.25% | +21.50% |
| Net Income Growth | +24.13% | +63.76% | +115.05% | -9.41% | +30.65% |
| EPS Growth | +18.53% | +75.00% | +111.38% | -9.82% | +36.36% |
| EPS Diluted Growth | +12.99% | +50.00% | +112.15% | -5.36% | +40.00% |
| Weighted Average Shares Growth | +1.39% | +1.83% | +1.78% | -0.60% | -2.59% |
| Weighted Average Shares Diluted Growth | +2.82% | +2.58% | +1.31% | -0.70% | -3.29% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +12.82% | +142.89% | +20.35% | +44.11% | +23.05% |
| Free Cash Flow Growth | -40.99% | +0.00% | +230.53% | +515.66% | +207.28% |
| Receivables Growth | +35.01% | +9.45% | -3.49% | +8.41% | +2.71% |
| Inventory Growth | -6.66% | +3.70% | -2.26% | +22.22% | +16.83% |
| Asset Growth | +14.32% | +14.98% | +12.60% | +19.37% | +21.39% |
| Book Value per Share Growth | +13.78% | +13.81% | +15.01% | +7.56% | +10.59% |
| Debt Growth | -33.49% | -29.07% | -44.74% | +240.29% | +132.27% |
| R&D Expense Growth | +23.35% | +6.27% | +11.74% | +2.38% | -25.53% |
| SG&A Expenses Growth | +16.88% | +17.11% | +10.55% | +17.15% | +16.10% |